Skip to content
naulon

Not checkedNot checked for notices yet.

Vi-TT—a typhoid conjugate vaccine for infants and young children

Thomas F Wierzba, Avinash K Shetty

The Lancet Global Health · 2021

doi:10.1016/s2214-109x(21)00470-8 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Salmonella enterica serovar Typhi (S Typhi) is the causative agent of typhoid fever. Globally, typhoid fever affected 9·24 million people and caused 110 000 deaths in 2019, primarily in areas lacking potable water and with poor sanitation.1 Infants and young children, especially those living in urban impoverished settings are at high risk. Multidrug-resistant strains are common.

Abstract licence: CC BY-NC

References10

  1. 7.
  2. 8.

8 more references, whose wording the paper’s licence keeps private.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.